Ingenia Therapeutics chairman Han Sang Yeul cuts stake to 74.60% from 76.80% in disclosure

Bitget2026/09/29 07:51

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Ingenia Therapeutics largest shareholder Han Sang Yeul disclosed a reduced stake to 36,885,969 shares, or 74.6%, as of Sept. 29.
Holding fell from 37,975,106 shares, or 76.8%, in the prior filing dated Aug. 25.
Change reflected 1,089,137 shares sold via on-market transactions; the disclosure cited a change report triggered on Sept. 18.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ingenia Therapeutics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260929000480), on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Ingenia Therapeutics chairman Han Sang Yeul cuts stake to 74.60% from 76.80% in disclosure

You may also like

Crypto prices